This application, """"""""Postdoctoral Research in Neurodevelopmental Disorders"""""""", is a request for five years of funding for the competing continuation of an NIH National Research Service Award (NSRA) Institutional Training Grant (T32). Recent advances in behavioral science, neuroscience and molecular genetics have led to dramatic gains in our understanding of the pathogenesis of neurodevelopmental disorders. The purpose of this training program is to develop researchers with expertise in both the biological basis and ? clinical manifestations of neurodevelopmental disorders. This broad-based and integrated perspective will enable researchers to better relate across disciplines and will maximize the potential for major research advances in understanding the pathogenesis and treatment of these disorders. The proposed postdoctoral training plan provides a variety of opportunities including: (1) mentored research training in specific methods, disorders and underlying pathogenetic mechanisms; (2) a range of didactic experiences (including courses, seminars and lectures) that integrate the study of clinical disorders, normal developmental processes, mechanisms of disease and research methods; and, (3) clinical exposures to complement previous levels of clinical experience. Twenty Ph.D. or M.D. level trainees (four new trainees per year) will participate in this two year training program, over the five year period of this application. This application addresses the critical need for focused training opportunities beyond formal graduate programs by using the existing interdisciplinary research and administrative structure of the University of North Carolina ? Neurodevelopmental Disorders Research Center (UNC NDRC), together with the excellent clinical and basic science resources of the University of North Carolina, to provide an ideal environment for integrating training in biological and behavioral research in neurodevelopmental disorders. ? ? ?
Lykken, Erik Allen; Shyng, Charles; Edwards, Reginald James et al. (2018) Recent progress and considerations for AAV gene therapies targeting the central nervous system. J Neurodev Disord 10:16 |
Greene, R K; Spanos, M; Alderman, C et al. (2018) The effects of intranasal oxytocin on reward circuitry responses in children with autism spectrum disorder. J Neurodev Disord 10:12 |
Tuttle, Alexander H; Molinaro, Mark J; Jethwa, Jasmine F et al. (2018) A deep neural network to assess spontaneous pain from mouse facial expressions. Mol Pain 14:1744806918763658 |
Swanson, Meghan R; Wolff, Jason J; Shen, Mark D et al. (2018) Development of White Matter Circuitry in Infants With Fragile X Syndrome. JAMA Psychiatry 75:505-513 |
Swanson, Meghan R; Shen, Mark D; Wolff, Jason J et al. (2018) Naturalistic Language Recordings Reveal ""Hypervocal"" Infants at High Familial Risk for Autism. Child Dev 89:e60-e73 |
den Bakker, Hanna; Sidorov, Michael S; Fan, Zheng et al. (2018) Abnormal coherence and sleep composition in children with Angelman syndrome: a retrospective EEG study. Mol Autism 9:32 |
Sidorov, Michael S; Judson, Matthew C; Kim, Hyojin et al. (2018) Enhanced Operant Extinction and Prefrontal Excitability in a Mouse Model of Angelman Syndrome. J Neurosci 38:2671-2682 |
Bailey, Rachel M; Armao, Diane; Nagabhushan Kalburgi, Sahana et al. (2018) Development of Intrathecal AAV9 Gene Therapy for Giant Axonal Neuropathy. Mol Ther Methods Clin Dev 9:160-171 |
Swanson, Meghan R; Shen, Mark D; Wolff, Jason J et al. (2017) Subcortical Brain and Behavior Phenotypes Differentiate Infants With Autism Versus Language Delay. Biol Psychiatry Cogn Neurosci Neuroimaging 2:664-672 |
Sidorov, Michael S; Deck, Gina M; Dolatshahi, Marjan et al. (2017) Delta rhythmicity is a reliable EEG biomarker in Angelman syndrome: a parallel mouse and human analysis. J Neurodev Disord 9:17 |
Showing the most recent 10 out of 137 publications